Use of PSA nadir to predict subsequent biochemical outcome following external beam radiation therapy for T1-2 adenocarcinoma of the prostate - Concepedia

Concepedia

Publication | Closed Access

Use of PSA nadir to predict subsequent biochemical outcome following external beam radiation therapy for T1-2 adenocarcinoma of the prostate

116

Citations

13

References

1996

Year

Anthony L. Zietman, M.K. Tibbs, K.C. Dallow, Christina T. Smith, Alex F. Althausen, Robert A. Zlotecki, William U. Shipley

Radiotherapy and Oncology

UrologySurgical OncologyRadiation MedicineRadiation TherapyT1-2 AdenocarcinomaSubsequent Biochemical OutcomeMedicineGenitourinary CancerProstatic DiseaseOncologyRadiation Oncology

References

	Year	Citations

Page 1

Page 1